PREVALENCE AND AWARENESS ABOUT TIRZEPATIDE INJECTION AMONG PHYSICIAN IN JEDDAH CITY
Abstract
Background: Tirzepatide injection is emerging as a treatment option for type 2 diabetes, yet its prevalence and awareness among healthcare practitioners remain underexplored, particularly in regions like Jeddah City. This study aims to fill this gap by assessing the prevalence and awareness of Tirzepatide injection among physicians in Jeddah City, Saudi Arabia.
Methods: A descriptive cross-sectional study was conducted among general practitioners at healthcare centers in Jeddah City from July 1 to July 31, 2023. Using convenient sampling, 160 participants were selected based on eligibility criteria, including familiarity with Tirzepatide injection. Data were collected through validated questionnaires covering sociodemographic characteristics and awareness of Tirzepatide injection. Statistical analysis was performed using SPSS software.
Results: Among the 160 participants, the majority were male general practitioners with a mean age of 33.03 years. The prevalence of Tirzepatide use among participants was 54.4%. The survey revealed varying levels of familiarity and confidence among healthcare professionals regarding Tirzepatide's mechanism of action, indications, dosage, contraindications, and effectiveness. Notably, there was a significant association between income level and awareness of Tirzepatide injection, with a higher awareness observed among participants with a good income.
Conclusion: The study sheds light on the prevalence and awareness of Tirzepatide injection among physicians in Jeddah City. While Tirzepatide is increasingly recognized as a treatment option for type 2 diabetes, there are notable gaps in awareness and confidence among healthcare professionals, particularly regarding its clinical application. Targeted educational interventions are warranted to enhance awareness and optimize the clinical use of Tirzepatide injection in managing type 2 diabetes in Jeddah City and beyond.
